October 19, 2017 6:35 PM ET


Company Overview of Par Pharmaceutical Companies Inc.

Company Overview

Par Pharmaceutical Companies, Inc. develops, licenses, manufactures, markets, and distributes generic drugs in the United States. It operates through two segments, Par Pharmaceutical and Par Specialty Pharmaceuticals. The Par Pharmaceutical segment markets generic products under Par Pharmaceutical brand name and sterile products under the Par Sterile brand. This segment also offers dosage forms and delivery systems, including oral solids and alternate dosage forms, such as oral solids, injectables, topicals, nasal sprays, ophthalmics, films, and transdermal patches. In addition, this segment markets pharmaceutical products, including Exforge, Lovaza, Precedex, Lamictal XR, Luvox CR, and Foca...

One Ram Ridge Road

Chestnut Ridge, NY 10977

United States

Founded in 1978

1,600 Employees





Key Executives for Par Pharmaceutical Companies Inc.

Chief Executive Officer and Director
Age: 55
Age: 60
Chief Financial Officer, Executive Vice President, Treasurer and Director
Age: 59
Senior Vice President and General Counsel of Generics
Chief Administrative Officer, General Counsel and Director
Age: 53
Compensation as of Fiscal Year 2017.

Par Pharmaceutical Companies Inc. Key Developments

Strides Shasun Limited Partners with Par Pharmaceutical to Market the Product in US

Strides Shasun Limited has partnered with Par Pharmaceutical to market product, Omega-3-Add Ethyl Esters Softgel capsules in the United States. The product to be manufactured in its facility in Bangalore will be launched immediately.

Par Pharmaceutical Receives U.S. FDA Approval of Ephedrine Sulfate Injection

Endo International plc announced that one of its operating companies, Par Pharmaceutical has received final approval from the U.S. Food and Drug Administration for its New Drug Application for ephedrine sulfate injection, a drug administered parenterally as a pressor agent to address clinically important hypotension in surgical settings. Ephedrine sulfate for injection is packaged in cartons of twenty-five 50mg/mL, 1mL single use vials.  Par expects to start shipping the product in February 2017.

Mylan, Allergan, Impax Laboratories, Lannett Co., Par Pharmaceuticals Companies, Sun Pharmaceutical Industries and West-Ward Pharmaceuticals Group Face Antitrust Lawsuit

Mylan NV and six other pharmaceutical companies are the targets of an antitrust lawsuit alleging that it illegally increased drug prices, including beefing up the price tags on doxycycline and digoxin. The plaintiff is the Rochester Drug Cooperative, a wholesale drug company based in Rochester, New York. The two drugs referenced in the suit are doxycycline, an antibiotic, and digoxin, a cardiac ailment treatment, which "exemplify this issue". Both drugs recently experienced a surge in pricing, doxycycline increasing 8,000% since October 2012, and digoxin increasing 800% since October 2013, according to the lawsuit. Other pharmaceutical companies named were Allergan, Impax Laboratories, Lannett Co., Par Pharmaceuticals Companies, Sun Pharmaceutical Industries and West-Ward Pharmaceuticals Group. Berger & Montague in Philadelphia, Faruqi & Faruqi in Jenkintown and Taus, Cebulash & Landau in New York City are representing the plaintiff.

Similar Private Companies By Industry

Company Name Region
1st Order Pharmaceuticals, Inc. United States
21st Century Animal Health United States
3 Buds' Organics LLC United States
4P Therapeutics LLC United States
60° Pharmaceuticals, LLC United States

Recent Private Companies Transactions

No transactions available in the past 12 months.

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
The Advertising Council, Inc. United States
NYC2012, Inc. United States
Tax Management Inc United States
Bertelsmann AG Europe

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Par Pharmaceutical Companies Inc., please visit www.parpharm.com. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.